Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events
- 30 June 2009
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 204 (2) , 503-508
- https://doi.org/10.1016/j.atherosclerosis.2008.11.002
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The combined effect of albuminuria and inflammation on all-cause and cardiovascular mortality in nondiabetic personsJournal of Internal Medicine, 2008
- Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso studyNephrology Dialysis Transplantation, 2008
- Repeated Weight Loss is Associated with the Metabolic Syndrome and Diabetes: Results of a 28 Year Re-screening of Men in the Oslo StudyMetabolic Syndrome and Related Disorders, 2007
- Prevalence and Prognostic Impact of Subclinical Cardiovascular Disease in Individuals With the Metabolic Syndrome and DiabetesDiabetes, 2007
- Primary Prevention of Ischemic StrokeStroke, 2006
- The association of microalbuminuria with clinical cardiovascular disease and subclinical atherosclerosis in the elderly: The Cardiovascular Health StudyAtherosclerosis, 2005
- Mechanism of albuminuria associated with cardiovascular disease and kidney diseaseKidney International, 2004
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- The world health organization monica project (monitoring trends and determinants in cardiovascular disease): A major international collaborationJournal of Clinical Epidemiology, 1988
- Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset DiabetesNew England Journal of Medicine, 1984